According to a survey conducted among people who took part in Veganuary worldwide in 2023, nearly half of the respondents intended to reduce their consumption of animal products by at least three quarters or more after Veganuary. Only one percent of respondents stated that they would not do so at all.

In 2022, the investment in plant-based companies amounted to nearly 2.1 billion U.S. dollars. By comparison, the annual investment in plant-based companies amounted to approximately 23 million U.S. dollars in 2010.

EPIC-Oxford is the Oxford component of the European Prospective Investigation into Cancer and Nutrition (EPIC), a large multi-centre cohort study with participants enrolled from 10 European countries. The EPIC-Oxford study began in the 1990s and follows the health of 65,000 men and women living throughout the UK, many of whom are vegetarian. The main objective of EPIC Oxford is to examine how diet influences the risk of cancer, particularly for the most common types of cancer in Britain, as well as the risks of other chronic diseases.

EPIC-Europe was initiated in 1992. It involves over 500,000 people from 23 centres in 10 European countries. It is coordinated by the World Health Organization International Agency for Research on Cancer in Lyon, and supported by the European Union and national funding agencies.

EPIC-Oxford is one of two EPIC cohorts in the UK, the other is EPIC-Norfolk.

For further details on the study design, recruitment, data collection and other aspects of the EPIC-Oxford study, please visit https://www.ceu.ox.ac.uk/research/epic-oxford-1

Proportion of the 2020 US human population who could be fed with food energy savings associated with vegan diets.